AGILE THERAPEUTICS INC - 00847L308

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q4 2023 · Q3 2023
Value (USD)
Total reported value ($000)
$479K
QoQ value delta ($000)
+$141K (+41.72%)
Implied price effect (QoQ)
-19.3%
Shares
Total shares
248,725
QoQ shares delta
+107,093 (+75.61%)
Total shares held by funds (by quarter)

Top holders (Q4 2023)

Top 25 only Full list
Early Q1 2024 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 210 108,000 0.0%
RENAISSANCE TECHNOLOGIES LLC 115 59,200 0.0%
VANGUARD GROUP INC 39 20,477 0.0%
CITADEL ADVISORS LLC 37 19,247 0.0%
GEODE CAPITAL MANAGEMENT, LLC 26 13,748 0.0%
STATE STREET CORP 21 10,843 0.0%
JPMORGAN CHASE & CO 15 7,712 0.0%
Tower Research Capital LLC (TRC) 6 3,276 0.0%
INVESTOR AB 3 1,754 0.0%
Advisory Services Network, LLC 3 2,020 0.0%
ROYAL BANK OF CANADA 2 798 0.0%
UBS Group AG 2 1,387 0.0%
WELLS FARGO & COMPANY/MN 0 19 0.0%
CITIGROUP INC 0 181 0.0%
MORGAN STANLEY 0 45 0.0%
COMERICA BANK 0 4 0.0%
GROUP ONE TRADING, L.P. 0 10 0.0%
OSAIC HOLDINGS, INC. 0 4 0.0%